Roumell Asset Management, LLC Bio Cardia, Inc. Call Options Transaction History

Roumell Asset Management, LLC

  • $51 Million
  • Q2 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding BCDA

# of Institutions
1
Shares Held
11.2K
Call Options Held
0
Put Options Held
0
View Full List

About BioCardia, Inc.

BCDA Quotes by TradingView
  • Ticker BCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,758,200
  • Market Cap $42.4M
  • Description
  • BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...
More about BCDA
Track This Portfolio

Track Roumell Asset Management, LLC Portfolio

Follow Roumell Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roumell Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roumell Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email